Probiotic nutrition is frequently claimed to improve human health. In particular, live probiotic bacteria obtained with food are believed to reduce pathogen colonization and thus, susceptibility to infection. However, the underlying mechanisms remain poorly understood. Here, we report that the consumption of probiotic Bacillus bacteria comprehensively abolishes colonization with the dangerous pathogen, Staphylococcus aureus. We discovered that the widespread fengycin class of Bacillus lipopeptides achieves colonization resistance by inhibiting the S. aureus Agr quorumsensing signaling system. Our study presents a detailed molecular mechanism underlining the importance of probiotic nutrition in reducing infectious disease. Notably, we provide human evidence supporting the biological significance of probiotic bacterial interference and show for the first time that such interference can be achieved by blocking a pathogen's signaling system. Furthermore, our findings suggest a probiotic-based method for S. aureus decolonization and new ways to fight S. aureus infections.
There is increasing appreciation of the key role that the intestinal microbiome plays in preventing the colonization and overgrowth of pathogens 1, 2 . The mechanisms that have been implicated in this beneficial function of probiotic bacteria are mostly indirect and include modulation of the immune system, enhancement of the intestinal epithelial barrier, or competition with pathogens for nutrients [2] [3] [4] [5] . Whether there is direct interference between probiotic and pathogenic bacteria is less clear. Some probiotic strains produce bacteriocins, which can kill phylogenetically related pathogenic bacteria 2 , and it has been shown that a bacteriocin-producing Escherichia coli strain inhibited colonization with related pathogenic bacteria in the inflamed gut of mice 6 . However, no evidence has been obtained to indicate that such mechanisms matter or are widespread in humans. Furthermore, it is not known whether there are ways of direct probiotic bacterial interference that are not mediated by bacteriocins.
The genus Bacillus comprises different species of soil bacteria that form endospores with the ability to survive harsh environmental conditions, such as the high temperatures encountered during cooking procedures. Bacillus spores are commonly ingested with vegetables 7 . They can subsequently germinate to form metabolically active, vegetative cells 8 , which can temporarily colonize the intestinal tract 9 . Given the dependence on dietary customs, the concentration of Bacillus spores in human feces is highly variable. It has been reported to be ~ 10 5 CFU/g in average, occasionally reaching up to 10 8 CFU/g 7 . Several probiotic formulae contain Bacillus species 10 , which are believed to reduce pathogen colonization by mechanisms that -except for a described immune-stimulatory effect on epithelial cells 11 remain poorly defined.
Staphylococcus aureus is a widespread and dangerous human pathogen that can cause a variety of diseases, ranging from moderately severe skin infections to fatal pneumonia and sepsis 12 . Treatment of S. aureus infections is severely complicated by antibiotic resistance 13 , such as in methicillin-resistant S. aureus (MRSA), and there is no working S. aureus vaccine 14 . Therefore, alternative strategies to combat S. aureus infections are eagerly sought 15 . Because S. aureus infections commonly originate from previous asymptomatic colonization 16, 17 , decolonization has recently gained considerable attention as a possible means to fight S. aureus infections in a preventive manner 18 . While the nares have traditionally been considered the primary S. aureus colonization site 19 , there is increasing evidence indicating that the intestinal tract is also commonly colonized by S. aureus [20] [21] [22] and forms an important reservoir for S. aureus infectious disease outbreaks 23, 24 . Several studies have reported levels of S. aureus in the feces of human adults of ~ 10 3 -10 4 CFU/ g [25] [26] [27] . Possibly, intestinal S. aureus colonization explains the failure of previous topical decolonization efforts aimed solely at the nose 16, 22, 28 .
Here, we hypothesized that the composition of the human gut microbiota affects intestinal colonization with S. aureus. To evaluate that hypothesis, we collected fecal samples from 200 healthy individuals from rural populations in Thailand (Fig. 1a ). This exemplary population was selected to rule out, as much as possible, food sterilization and antibiotic presence as used frequently in highly developed urban areas, which potentially could diminish the abundance of probiotic bacteria in the food and the intestinal tract of the participating subjects. Our analysis revealed a comprehensive Bacillus-mediated S. aureus exclusion effect in the human population. By demonstrating that quorum-sensing is indispensable for S. aureus intestinal colonization and discovering that secreted Bacillus fengycin lipopeptides function as quorum-sensing blockers to achieve complete eradication of intestinal S. aureus, we provide evidence strongly suggesting that this pathogen exclusion effect in humans is due to a widespread and efficient probiotic-mediated mechanism that inhibits pathogen quorum-sensing signaling.
S. aureus exclusion by Bacillus
S. aureus intestinal carriage as determined by growth from fecal samples was found in 25/200 (12. 5%) of human subjects. Nasal carriage was similar in frequency (26/200; 13%) , a result that is in accordance with previous findings showing a correlation between nasal and intestinal colonization 22 . These rates are considerably lower than those commonly found in adult populations during cross-sectional culture-based surveys that were mainly performed in hospital-admitted individuals in urbanized areas (on average, ~ 20% for intestinal and ~ 40% for nasal carriage) 16, 21, 22 .
To examine the hypothesis that bacterial interactions in the gut determine intestinal S. aureus colonization, we first analyzed the composition of the gut microbiome by 16S rRNA sequencing. However, we did not detect significant differences in the composition of the microbiome between S. aureus carriers and non-carriers (Extended Data Fig. 1 ).
In contrast, we found a striking correlation between the presence of Bacillus bacteria and absence of S. aureus. Bacillus species (mostly B. subtilis, Extended Data Fig. 1 ) were found in 101/200 (50.5%) of subject samples. S. aureus was never detected in fecal samples when Bacillus species were present (p<0.0001, Fisher's exact test) ( Fig. 1b ). Furthermore, this pathogen exclusion effect was not limited to the site of interaction, the gut, but extended to S. aureus colonization in a general fashion. While Bacillus was generally absent from nasal samples, S. aureus nasal colonization was never detected in the presence of intestinal Bacillus (p<0.0001, Fisher's exact test) ( Fig. 1c ). Interestingly, the levels of S. aureus colonization we found in non-Bacillus-colonized individuals from rural Thailand approximately match those reported, using similar culture-based assays, in urbanized Western areas. These findings indicate a widespread mechanism exerted by Bacillus species that comprehensively inhibits colonization with S. aureus. Moreover, they suggest that S. aureus colonization is increased in urban populations due to the lack of a probiotic, Bacilluscontaining diet. Intriguingly, they also imply that the intestinal site plays a previously underappreciated role in determining general S. aureus colonization, a notion in accordance with findings attributing a key role to fecal transmission in MRSA re-colonization 28 .
When we analyzed data from previous 16S rRNA-sequencing-based microbiome studies, we found strongly variant results and no correlation between the absence of S. aureus and the presence of B. subtilis: Studies that reported considerable B. subtilis or S. aureus numbers (samples with colonization by either species > 10%) did not reveal exclusion phenomena (average 14.89 ± 15.69% colonization by both species) (Extended Data Fig. 2 ). While we did not find a correlation, we feel this may be due to the fact that such sequencing-based analyses are set up to detect high-order taxonomic shifts rather than specific differences on the species or genus level.
Quorum-sensing and colonization
Our results showing no significant high-order taxonomic differences in the microbiome composition between S. aureus carriers and non-carriers exclude an indirect effect of Bacillus on the microbiome composition. Rather, we hypothesized that the Bacillus isolates produce a substance that directly and specifically inhibits S. aureus intestinal colonization. We first analyzed whether there is a growth-inhibitory effect of the Bacillus isolates on S. aureus. However, only a minor growth inhibition occurred in 6 out of 105 isolates (maximally 1 mm inhibition zone when analyzed using an agar diffusion test with five-times concentrated culture filtrate). This fails to explain the observed complete correlation between the presence of Bacillus and absence of S. aureus, and rules out a bacteriocinmediated phenomenon.
It is poorly understood which factors are important for S. aureus intestinal colonization.
Only one mouse study implicated wall teichoic acids and the surface protein, clumping factor A (ClfA) 29 . Prompted by our previous finding that ClfA is positively regulated by the Agr quorum-sensing system 30 , we hypothesized that the Bacillus isolates secrete a substance that interferes with quorum-sensing signaling. Quorum-sensing is responsible for sensing the density of the bacterial population ("quorum") and controlling the concomitant alteration of cell physiology 31 . As quorum-sensing signals and sensors differ between different types of bacteria 31 , an underlying quorum-quenching mechanism would explain the specificity of the inhibitory effect that we detected.
Because the role of quorum-sensing in S. aureus intestinal colonization is unknown, we first used a mouse model of S. aureus intestinal colonization to test whether Agr quorum-sensing plays a role ( Fig. 2a ). In all mouse models in our study, we included (i) a human fecal isolate belonging to a sequence type (ST) frequently detected in the obtained fecal isolates (ST2196), according to multi-locus sequence typing (MLST) we performed (Supplementary Tab. 1), (ii) a mouse infection isolate (ST88) 32 , and (iii) a human infection isolate of the highly virulent MRSA type USA300 33 . In competition experiments with equal amounts of wild-type and isogenic agr mutant strains, only wild-type S. aureus were detected in the feces and colonized the large and small intestines at the end of the experiment (competition index ≥ 100) ( Fig. 2b , Extended Data Fig. 2 a,b ). Furthermore, in a non-competitive experimental setup, only those bacteria expressing the intracellular Agr effector RNAIII 34 achieved colonization, while agr-negative control strains never did ( Fig. 2c , Extended Data Fig. 2c ). These data show that in addition to its well-known role in infection 30, 35 , the Agr quorum-sensing system is absolutely indispensable for intestinal colonization.
Fengycin quorum-quenchers
Having established that the Agr quorum-sensing regulatory system is essential for S. aureus intestinal colonization, we analyzed whether culture filtrates of the Bacillus isolates collected from human feces can inhibit Agr. To that end, we used an S. aureus reporter strain, in which we had transferred the luminescence-conferring luxABCDE operon into the genome under control of the Agr P3 promoter 34 , which controls production of RNAIII. Remarkably, culture filtrates from all 105 isolates reduced Agr activity in that assay by at least 80% ( Fig. 3a , Extended Data Tab. 1). No growth effects were observed, substantiating that growth inhibition does not underlie the inhibitory phenotype. Furthermore, culture filtrate from a reference B. subtilis strain suppressed the production of key Agr-regulated virulence factors (phenol-soluble modulins, α-toxin, and Panton-Valentine leukocidin) ( Fig.  3b ,c, Supplementary Fig. 1 ). These results indicated that the inhibitory effect of the Bacillus isolates on S. aureus colonization is due to a secreted substance that inhibits Agr signaling.
To characterize the Agr-inhibitory substance, we performed experiments with culture filtrate of the reference B. subtilis strain. The substance in question was thermostable and resistant to protease digestion (Extended Data Fig. 3 a) . In reversed-phase high performance chromatography (RP-HPLC) (Extended Data Fig. 3b ), significant Agr-inhibiting activity was associated with two peaks, which we then analyzed by RP-HPLC/electrospray ionization mass spectrometry (ESI-MS) (Extended Data Fig. 3c ). This analysis, together with the elution behavior and published literature 36 , allowed us to identify the substances as members of the fengycin cyclic lipopeptide family. Because fengycins can differ in specific amino acids in addition to the length of the attached fatty acid, which usually is βhydroxylated (β-OH), and different Bacillus strains produce somewhat different fengycin species 37 , we used further tandem mass spectrometric fragmentation analysis (MS/MS) to identify the specific fengycins present in the two active peaks (Extended Data Fig. 3d ). Fengycins in the first peak were identified as β-OH-C17-fengycin A and β-OH-C16fengycin B. The second peak consisted of one fengycin species, β-OH-C17-fengycin B. Smaller, adjacent peaks also contained fengycin species according to RP-HPLC/ESI-MS analysis, which we tentatively identified as β-OH-C17-fengycin A and the de-hydroxylated versions of the identified three major fengycins (Extended Data Fig. 3e ). For further analyses, higher amounts of β-OH-C17-fengycin B were purified to homogeneity from culture filtrate and dose-dependent Agr-inhibiting activity of this pure substance was verified (Extended Data Fig. 4 ).
Using RP-HPLC/ESI-MS analysis, we found fengycin production in all isolates, substantiating the general character of the inhibitory interaction (Extended Data Tab. 1). While the production pattern of different fengycins varied in the analyzed isolates, in many of them β-OH-C17-fengycin B was the most strongly produced type. Notably, almost complete inhibition of Agr was detected at a concentration of ~ 1.4 μM total fengycin ( Fig.  3d ). This corresponds to the median concentration of total fengycin produced by stationary phase-cultures of the Bacillus isolates (1.5 μM) ( Fig. 3e ).
To provide definitive evidence that fengycin production underlies the Agr-inhibiting capacity of Bacillus, we produced an isogenic mutant in the reference B. subtilis strain of the fenA gene, which is essential for fengycin production 38 . RP-HPLC/ESI-MS showed specific absence of fengycins in that mutant strain, while surfactins, the predominant Bacillus lipopeptides, were still present (Extended Data Fig. 3f ). Culture filtrate of the fenA mutant strain was devoid of Agr-inhibiting activity in contrast to that of the isogenic wild-type strain ( Fig. 3f ). We also measured an isogenic surfactin-negative mutant strain, which showed Agr-inhibiting activity similar to the wild-type strain (Fig. 3f ). These results confirmed that fengycin production is the source of the observed Agr inhibition.
Mechanism of fengycin inhibition
In the S. aureus Agr quorum-sensing regulatory circuit, the secreted Agr autoinducingpeptide (AIP) interacts with an extracellular domain of AgrC, the histidine kinase part of a two-component signal transduction system, to signal the cell density status (Fig. 4a) 39 . Different Agr subgroups of S. aureus, as well as different staphylococcal species, produce cyclic hepta-to nonapeptide AIPs 35 . AIPs from different subgroups or species frequently inhibit Agr signal transduction by competitive inhibition at the AgrC binding site [39] [40] [41] . Given that fengycins as cyclic lipopeptides show structural similarity to AIPs (Fig. 4b ), it appears likely that fengycins compete with the natural AIP for AgrC binding. The only other theoretically possible site of interference from the extracellular space would be the membrane-located AIP production/secretion enzyme AgrB. Using an S. aureus agrBD deletion strain and stimulation of AgrC by synthetic AIP, which led to complete Agr inhibition, we ruled out that the target of Agr inhibition by Bacillus is AgrB (Fig. 4c ). In further support of a mechanism that works by competition with AIP for binding to the AgrC receptor, fengycin inhibition could be reversed in a dose-dependent fashion by addition of AIP ( Fig. 4d ). Finally, we determined the AIP concentration in early stationary growth phase (6-8 h) to be ~ 1 μM (Extended Data Fig. 5a ), which is approximately equal to the concentration of fengycin for which we found complete Agr inhibition ( Fig. 3d ). These findings indicate that fengycins inhibit Agr signal transduction by efficient competitive inhibition as structural analogues of AIPs.
The fact that AgrC-AIP interaction differs by Agr subtype raises the question whether fengycins have general ability to inhibit Agr. We found that purified β-OH-C-17 fengycin B inhibited Agr in members of all S. aureus Agr subtypes, as well as in S. epidermidis ( Fig.  4e ). Furthermore, the S. aureus strains used in the mouse experiments belong to different Agr subtypes (USA300, type I, ST88, type III, ST2196, type I). These results indicate that fengycins have broad-spectrum Agr-inhibiting activity.
Bacillus spores eradicate S. aureus
To validate our findings in vivo and demonstrate the specific role of fengycins in the inhibition of S. aureus intestinal colonization, we compared the impact of the B. subtilis wild-type reference strain and its isogenic fenA mutant on S. aureus colonization in a mouse intestinal colonization model. We first performed a control experiment analyzing the colonization kinetics of B. subtilis when given as spores, which corresponds to the form Bacillus would be taken up with food or probiotic formulae (Extended Data Fig. 5b ). We observed transient colonization that strongly declined within two days. Importantly, colonization by the fenA mutant was not different from that by the B. subtilis wild-type strain, ruling out that fengycin production per se impacts B. subtilis colonization.
Feeding mice B. subtilis spores completely abrogated colonization of all tested S. aureus strains in the feces and intestines, in experimental setups with or without antibiotic pre-treatment to eliminate the pre-existing microbiota. (Fig. 5b ,c, Extended Data Fig. 5c-f ). In contrast, spores of the fenA mutant had no significant effect on colonization of any S. aureus test strain. As Bacillus intestinal colonization in humans has been shown to reach much higher levels than that by S. aureus 7 , a situation highly likely to be even more pronounced in the tested rural population, our mouse data obtained with S. aureus numbers approximately equaling or exceeding those of applied Bacillus spores suggest that fengycin-mediated quorum-sensing interference contributes to the S. aureus colonization exclusion we observed in humans.
Conclusions
Scientific evidence to support the frequent claims that probiotic nutrients improve human health is scarce. This study provides evidence for a molecular mechanism of probiotic food bacteria-mediated direct interference that limits pathogen colonization. In particular, our data underscore the often-debated 10,42 probiotic value of B. subtilis. Interestingly, we found the responsible agents to work by quorum-quenching, demonstrating that pathogen exclusion in the gut may work by inhibition of a pathogen signaling system. Furthermore, our findings emphasize the importance of quorum-sensing for pathogen colonization.
Our study suggests several highly valuable translational applications regarding alternative strategies to combat antibiotic-resistant S. aureus. First, the quorum-quenching fengycins, which previously had only been known for their anti-fungal activities 43 , may be used as quorum-sensing blockers for eagerly sought antivirulence-based efforts to treat staphylococcal infections 15, 44 . Second, Bacillus-containing probiotics may be used for simple and safe S. aureus decolonization strategies. In that regard, it is particularly noteworthy that our human data indicate that probiotic Bacillus can comprehensively eradicate intestinal as well as nasal S. aureus colonization. Such a probiotic approach would have multiple advantages over the current standard topical strategy with antibiotics, which is aimed exclusively at decolonizing the nose 45 .
Methods
No statistical methods were used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment, except for when noted.
Sample collection and bacterial screening
Nasal swabs and fecal samples were obtained from 200 Thai healthy volunteers from four different locations in southern, central, northeastern, and northern Thailand. One sterile nasal swab, a sample collection tube, a sterile container, and tissue paper were given to each participant. All participants provided informed written consent. The study was performed in compliance with all relevant ethical regulations and approved by the Siriraj Institutional Review Board (approval no. Si 733/2015). All participants were over 20 years old (age range: 20-87, median 57±14.5; 131 women and 69 men) and without history of intestinal disease. None had received any antibiotic treatment or stayed at a hospital within at least three months prior to the study. Nasal swabs and fecal samples were streaked on mannitol salt agar (MSA) and then incubated at 37 °C for 24 hours. Positive or negative S. aureus or Bacillus colonization could easily be distinguished by either strong growth on the entire plate, or absence of any colonies, respectively. At the time of this analysis, the purpose of the analysis was to obtain and archive colonizing S. aureus strains. As the hypothesis on Bacillus-S. aureus exclusion was only developed from the results of this analysis, the staff performing the analysis were blinded as for the exclusion hypothesis. Isolates were easily recognized as S. aureus or Bacillus by colony morphology and color; however, every isolate was confirmed for species identity using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (see below), and Bacillus species were also further distinguished by 16S rRNA sequencing (Extended Data Tab. 1). To that end, 16S rRNA genes were PCR-amplified using primers 27FB and 1492RAB 46 and BLAST similarity analysis was used to identify the species. Subjects were considered as permanently colonized by S. aureus if two positive samples were obtained, tested in a 4-week interval. All individuals tested either negative or positive for S. aureus at both times. In total, 105 Bacillus isolates from 101 individuals were analyzed. In the samples from four individuals, two isolates each were taken due to apparent phenotypic differences.
Bacterial identification using MALDI-TOF MS
Isolates were inoculated onto sheep blood agar and incubated for 24 h at 37 °C. Bacterial colonies were applied onto a 96-spot target plate and allowed to dry at room temperature. Subsequently, 2 μl of MALDI matrix [a saturated solution of α-cyano-4-hydroxycinnamic acid (HCCA) in 50% acetonitrile and 2.5% trifluoroacetic acid] was applied onto the colonies and allowed to dry before testing. Then the target plate was loaded into the MALDI-TOF MS instrument (MicroFlex LT mass spectrometer, Bruker Daltonics). Spectra were analyzed using MALDI Biotyper automation control and the Bruker Biotyper 2.0 software and library (version 2.0, 3,740 entries; Bruker Daltonics). Identification score criteria used were those recommended by the manufacturer: a score of ≥ 2.000 indicated species-level identification, a score of 1.700 to 1.999 indicated identification to the genus level, and a score of <1.700 was interpreted as no identification. Isolates that failed to produce a score of <1.700 with direct colony or extraction methods were retested. S. aureus ATCC25923, E. coli ATCC25922 and Pseudomonas aeruginosa ATCC27853 were used as controls.
Bacterial strains and growth conditions
The reference B. subtilis strain and parent of the fenA and srfA mutants used in this study was strain ZK3814 (genotype NCIB3610). The S. aureus strains used in all experiments (except the experiment analyzing different Agr-subtype S. aureus) were (i) the human fecal isolate F12 of ST2196 (Supplementary Tab. 1), (ii) strain JSNZ of ST88, a mouse isolate previously described as mouse-adapted 32 , (iii) strain LAC of pulsed-field type USA300, an MRSA lineage predominantly involved in community-associated infections, but now generally representing the major lineage responsible for S. aureus infections in the United States 47 .
Isogenic mutants in agr were previously described (for strain LAC) 48 or produced in this study (for strains JSNZ and F12) by phage transduction of the agr deletion from strain RN6911. The agr system is entirely deleted in these strains, except for a 3' part of RNAIII, which is not transcribed owing to the absence of the corresponding promoter. All mutants were verified by analytical PCR.
Due to the tetracycline resistance introduced in the agr deletion strains, kanamycin derivatives (pKX Δ ) of the pTX Δ expression plasmid series were constructed and used for complementation of Agr. (This was not possible in strain LAC, which harbors multiple antibiotic resistance including to kanamycin). To that end, plasmid pKX15 49 kindly provided by B. Krismer, University of Tübingen, was treated as described 48 to delete the xylR promoter to make expression of any fragment cloned under control of the xyl promoter constitutive. To obtain plasmid pKX Δ RNAIII, the RNAIII BamH1-MluI fragment was transferred from pTX Δ RNAIII 50 . Plasmid pTX Δ 16 is the corresponding empty control plasmid.
To construct the agrBD deletion mutant of strain LAC P3-lux, a 4.8 kb-PCR product from USA300 genomic DNA that included the agrBDCA operon, 1 kb upstream, and 1 kb downstream, was cloned into the SmaI site of pIMAY 51 and inverse PCR was used to delete agrBD. Allelic exchange was then performed, and the chromosomal deletion was confirmed by PCR using one primer outside of the 1 kb homology arm, followed by sequencing the PCR product. See Supplementary Table 2 for oligonucleotides used.
To construct the tetracycline-resistant derivatives of S. aureus ST88 and ST2196, φ11 phage-mediated transduction was performed as described to transfer the tetracycline cassette in the donor strain (S. aureus RN4220 with integrated pLL29) to S. aureus ST88 and ST2196 52 .
To construct the B. subtilis fengycin mutant strain, SPP1 phage-mediated transduction 53 was performed to transfer the fenA deletion present in the donor strain (BKE18340 -a fenA(ppsA)::erm mutant in B. subtilis 168 obtained from the Bacillus Genetic Stock Center) to B. subtilis ZK3814. This was necessary as B. subtilis 168 bears a mutation in the sfp gene abolishing lipopeptide production.
Bacteria were generally grown in tryptic soy broth (TSB) with shaking unless otherwise indicated.
Typing of S. aureus isolates
S. aureus isolates were typed by multi-locus sequence typing (MLST) as previously described 54 . PCR amplicons of seven S. aureus housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi, and yqiL) were obtained from chromosomal DNA and their sequences compared with those available at the PubMLST database (https://pubmlst.org/saureus/). Not previously described alleles (arcC 520-521 and gmk 337) and STs (STs 4630 -4638) were deposited to the website. The Agr subtype of S. aureus isolates was determined using a modified multiplex qRT-PCR protocol 55 . Two duplex qRT-PCR protocols using the respective described primer sets and two colored probes each were set up for Agr types I and II, and III and IV, respectively. Isolates whose Agr type could not be determined by that method were analyzed for the type of AIP production using HPLC/MS with the chromatography method also used for PSM detection (see below), integrating the three major m/z peaks for each AIP type.
Microbiome analysis
Genomic DNA from each fecal sample was extracted using a QIAamp DNA stool Minikit (Qiagen) according to the manufacturer's instructions. The DNA was quantified using a Nanodrop spectrophotometer and 16S rRNA paired-end sequencing of the V4 region of 16S rRNA was performed by Illumina (San Diego, California) using an Illumina MiSeq system as described 56 .
For all obtained paired-end sequences, the abundance of Operational Taxonomic Units (OTU) and alpha and beta diversity were identified using Quantitative Insights Into Microbial Ecology (QIIME 1.9.1) 57 . This study used the Nephele (release 1.6) platform from the National Institute of Allergy and Infectious Diseases (NIAID) Office of Cyber Infrastructure and Computational Biology (OCICB) in Bethesda, Maryland. The sequences were assigned to OTUs with the QIIME's uclust-based 58 open-reference OTU picking protocol 59 and the Greengenes 13_8 reference sequence set 60 at 99% similarity. Alpha diversity was calculated using Chao1 and Shannon analyses 61 and compared across groups using a nonparametric t test with 999 permutations.
Growth inhibition analysis
Growth inhibition of S. aureus by Bacillus culture filtrates was tested with an agar diffusion assay. To that end, 10 μl of Bacillus culture filtrate of each isolate was spotted on sterile filter disks. The filters were let to dry and the procedure was repeated four times, after which filters were laid on agar plates containing S. aureus, resulting in the analysis of five-times concentrated culture filtrate.
Fengycin purification
To identify the Agr-inhibiting active substance, 10 ml culture filtrate of the B. subtilis reference strain grown for 48 h in TSB were applied to a Zorbax SB-C18 9.4 mm x 25 cm reversed-phase column (Agilent) using an AKTA Purifier 100 system (GE Healthcare). After washing with three column volumes with 100% buffer A [0.1% trifluoroacetic acid (TFA) in water] and five column volumes of 30% buffer B (0.1% TFA in acetonitrile), a 20-column volume gradient from 30 to 100% buffer B was applied. The column was run at a flow rate of 3 ml/min. Peak fractionation was performed using the absorbance at 214 nm and fractions were subjected to further analysis by RP-HPLC/ESI-MS and MS/MS and test for Agr inhibition (see below).
To purify larger amounts of the main active peak containing β-OH-C17-fengycin B, acetonitrile was added to 200 ml filtrate from cultures grown under the same conditions to a final concentration of 10%, precipitated material was removed by centrifugation for 10 min at 3700 x g using a Sorvall Legend RT centrifuge, and the obtained cleared supernatant was applied to a self-packed HR 16/10 column filled with Resource PHE (GE Healthcare) material (column volume, 17 ml). After sample application, the column was washed with 10 % buffer B for three column volumes and 25% buffer B for five column volumes, after 
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Author Manuscript which a gradient of 15 column volumes from 25 to 60% buffer B was applied. 10-ml fractions were collected and positive fractions (as determined by RP-HPLC/MS) were lyophilized. The lyophilisate was redissolved in 2 ml acetonitrile. Six ml of water was added and the precipitated material was removed by 5 min centrifugation in a tabletop centrifuge at maximum speed. The cleared supernatant was then further purified on a Zorbax SB-C18 9.4 mm x 25 cm reversed-phase column as described above.
PSM and lipopeptide detection by RP-HPLC/MS
PSMs were analyzed by RP-HPLC/ESI-MS using an Agilent 1260 Infinity chromatography system coupled to a 6120 Quadrupole LC/MS in principle as described 62 , but with a shorter column and a method that was adjusted accordingly. A 2.1 × 5 mm Perkin-Elmer SPP C8 (2.7 μm) guard column was used at a flow rate of 0.5 ml/min. After sample injection, the column was washed for 0.5 min with 90% buffer A /10% buffer B, then for 3 min with 25% buffer B. Then, an elution gradient was applied from 25% to 100% buffer B in 2.5 min, after which the column was subjected to 2.5 min of 100% buffer B to finalize elution.
Bacillus culture filtrates or (partially) purified lipopeptide (fengycins, surfactins) containing fractions were analyzed using the same column, system, and elution conditions. To quantify production of different fengycins, the two most abundant peaks, corresponding to double and triple charged ions, were used for the integration. Agilent Mass Hunter Quantitative Analysis Version B.07.00 was used for quantification.
Measurement of Agr activity
To determine the Agr-inhibiting activity of Bacillus culture filtrates or purified fractions, we measured luminescence emitted by an Agr P3 promoter-luxABCDE reporter fusion construct that was inserted into the genome of strain S. aureus LAC 34 . Strain LAC P3-luxABCDE was diluted 100-fold from a pre-culture grown overnight in TSB before distribution into a 96-well microtiter plate. To 100 μl of that dilution, 100 μl of sterilized culture filtrate sample was added, unless otherwise indicated. Plates were incubated at 37°C with shaking. Luminescence was measured with a GloMax Explorer luminometer (Promega) every 2 h for a total of 6 h. Inhibition was considered significant if the 4-h sample and control values differed by at least a factor of 2. Of note, the quorum-quenching effect exerted by the one-time initial dose of fengycin or fengycin-containing culture filtrates was transient and was overcome at later times by the increasing intrinsic AIP production. Agr-inhibiting activity of purified fengycin was also measured using quantitative real-time PCR of RNAIII as described previously 30 .
To determine the Agr-inhibiting activity on target strains other than LAC (Agr subtype I), the impact on the production of δ-toxin, whose gene is embedded in the Agr intracellular effector RNA, RNAIII, in most staphylococci, was used. Production of δ-toxin was measured by RP-HPLC/ESI-MS as described above. 
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Analysis of PVL and α−toxin expression
S. aureus strain LAC was diluted 100-fold from a pre-culture grown in TSB and inoculated into 500 μl TSB. Two hundred and fifty μl of B. subtilis culture filtrate was added into the sample. Samples were incubated at 37 °C with shaking for 4 h. Samples were centrifuged in a tabletop centrifuge at maximum speed for 5 min; the supernatants were collected and loaded onto 12% SDS-PAGE gels, which were run at 160 V for 1 h. Proteins were transferred to nitrocellulose membranes using an iBlot Western blotting system. Membranes were incubated with Odyssey blocking buffer for 1 h at room temperature. Anti-α-toxin (polyclonal rabbit serum; Sigma S7531; dilution 1:5,000) or anti-LukF-PV (affinity-purified rabbit IgG specific for a peptide region of LukF-PV, produced by GenScript USA Inc. and kindly provided by F. DeLeo, NIAID; dilution 1:500) antibodies were added to the blocking buffer and membranes were incubated overnight at 4 °C. Then, membranes were washed five times with Tris-buffered saline containing 0.1% Tween-20, pH 7.4 and incubated with Cy5-labeled goat anti-rabbit IgG (diluted 1:10,000 in blocking buffer) in the dark for 1 h at room temperature. Membranes were washed five times with the washing buffer and scanned with a Typhoon TRIO+ Variable Mode Imager.
Preparation of Bacillus spores
B. subtilis wild-type or isogenic fengycin mutant strains were inoculated from a pre-culture (1:100) into 1 l of 2 x SG medium 63 and allowed to sporulate for 96 hours. Cells were pelleted, washed with water, and resuspended in 20% metrizoic acid (Sigma). Five different concentrations (w/v) of metrizoic acid (60% -20%) were added stepwise to a 50-ml centrifuge tube to obtain a density gradient. Then, a cell suspension was added to the top of the gradient, followed by centrifugation at 40,000 × g for 60 min at 4 °C 64 . Spores were found in the middle layers and were collected. They were washed with 10 ml water for three times. The total obtained number of viable spores per ml was determined by serial dilution, plating on TSA, and counting CFUs. The total number of heat-resistant spores per ml was determined by submerging the spores in water bath at 80 °C for 20 min followed by serial dilution and quantification of CFU/ml as described above.
Murine intestinal colonization model
In-vivo studies were approved by the Institutional Animal Care and Use Committee of the NIAID. Animal work was conducted adhering to the institution's guidelines for animal use, and followed the guidelines and basic principles in the United States Public Health Service Policy on Humane Care and Use of Laboratory Animals, and the Guide for the Care and Use of Laboratory Animals by certified staff in an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International accredited facility.
All C57BL/6J mice were female and six to eight weeks of age at the time of use. In one setup, before S. aureus was given by oral gavage, mice were pre-treated to eradicate the preexisting intestinal microbiota using an antibiotic mix consisting of ampicillin (1 g/l), metronidazole (1 g/l), neomycin trisulfate (1 g/l), and vancomycin (1 g/l), in the drinking water. The last day before gavage, antibiotics were omitted from the drinking water. No bacteria could be found in the feces or intestines of mice for 7 days after this treatment in a control experiment. In another setup, antibiotic pre-treatment was omitted. In all setups, S. aureus strains were grown to mid-exponential growth phase, washed, and resuspended in sterile PBS at 10 8 CFU/ml. Mice were inoculated by oral gavage with 200 μl of a 10 8 CFU/ml suspension of the indicated S. aureus strains, or 1:1 mixtures of wild-type and isogenic agr mutants to reach the same final concentration and volume. For the experiments with pKX Δ plasmid-containing strains, mice received kanamycin (0.2 g/l) in the drinking water during the experiment to maintain plasmids. For the B. subtilis spore competition experiment, oral gavage with 200 μl of spores of the Bacillus wild-type or its isogenic ΔfenA fengycin mutant (10 8 CFU/ml in sterile PBS) was performed on the day following the S. aureus gavage, and repeated every second day thereafter for a total of 3 times (days 2, 4, and 6). Intestinal colonization was evaluated by quantitative cultures of mice stool samples and samples from the small and large intestine. In detail, stool was collected and suspended to a final volume of 1 ml of PBS, diluted, and plated on TSB agar. Plates were incubated for 24 h at 37 °C, and colonies were enumerated. Moreover, after mice were euthanized seven days after infection, the small and large intestines were collected, resuspended each in 1 ml PBS, and homogenized. Serial dilutions of the homogenates were plated on TSB agar and incubated at 37 °C. Bacterial colonies were enumerated on the following day. In the experiments without antibiotic pre-treatment, extracts were plated on MSA plates containing 4 μg/ml oxacillin (for strain USA300 LAC) or 3 μg/ml tetracycline (for tetracycline-resistant derivatives of ST88 and ST2196), incubated for 48 h at 37 °C, and enumerated.
Statistics
Statistical analysis was performed using GraphPad Prism Version 6.05 using 1-way or 2-way ANOVA, or Fisher's exact test, as appropriate, except for the experiments shown in Figures  2c, 5b 
Data availability
Microbiome sequencing data are available at http://www.ncbi.nlm.nih.gov/bioproject/ 483343. All other data generated or analyzed during this study are included in this published article or in the supplementary information files.
Extended Data Figure 2 |. Quorum-sensing dependence of S. aureus intestinal colonization.
Data from strains USA300 LAC and ST88 JSNZ. The experimental setup is the same as in 
